概括
胃外科手术患者在20年后面临胃癌风险增加. 双胞胎手术患者也显示出延迟的风险增加,可能与手术方法和胆汁反流有关.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 手术研究的研究.
背景情况:
- 之前关于胃外科手术和胃癌风险的研究已经产生了相互矛盾的结果.
- 了解手术后的长期癌症风险对于患者管理至关重要.
研究的目的:
- 调查1940年至1960年间为胃进行胃外科手术的患者胃癌死亡的长期风险.
- 分析的类型 (胃与十二指肠) 和手术程序如何影响这种风险.
主要方法:
- 一组4466名经过胃外科手术的病患者与匹配的人口组进行了比较.
- 分析了随访数据,以评估胃癌随时间推移的死亡率.
- 风险根据原始病理和特定的外科手术 (例如胃切除术,干部阴道切除术和排水,Bilroth I,Bilroth II) 进行了分层.
主要成果:
- 在胃部手术后的头20年中,没有观察到胃癌风险的增加,但随后发生了4.5倍的增加.
- 十二指肠患者最初的风险降低,随后在20多年后增加3.7倍.
- 胃患者的风险在20年内增加了3.0倍,随后增加到5.5倍. 20年后,比尔罗特II患者的风险高于比尔罗特I患者的风险.
结论:
- 胃手术后胃癌死亡的长期风险显著增加,特别是在20年后.
- 风险取决于最初的类型和所采用的特定手术程序.
- 研究结果表明,诸如粘膜表面减少和胆汁反流等因素可能导致手术后胃癌发生.
相关概念视频
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...


